CELZNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$0.72−0.02 (-2.35%)
Close on Oct 19, 2026
- Market cap
- $2.68M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Creative Medical Technology has not reported a dividend
No dividend per share appears in Creative Medical Technology's annual filings since fiscal 2010.